Market News How it works Learn FAQ
| RCT 0.132 73.46% | NU 12.36 -18.47% | EWZ 33.885 -20.44% | TGL 0.254 14.67% | SRTM 0.326 -24.24% | BBD 2.855 -29.85% | ITUB 7.6 -21.41% | AZTR 1.615 125.87% | SHFS 0.103 -22.21% | XP 15.575 -48.78% | GCDT 0.1361 -22.71% | CLRO 4.79 47.38% | SOXL 91.64 9.67% | SPCX 149.92 1.65% | NWGL 0.0829 1.10% | PBR 21.94 -16.13% | NVD 3.99 -4.77% | SGRY 23.0703 46.48% | TSLL 10.9599 12.29% | VALE 11.99 -3.31% | RBNE 0.1701 -10.47% | CRWV 57.4626 5.95% | INTC 90.785 4.40% | NVDA 216.2072 2.49% | SOXS 47.41 -9.63% | BITO 10.77 -0.55% | ABEV 2.8 -15.15% | IREN 26.5486 6.60% | JBLU 2.295 -12.57% | NOK 8.625 5.96% | XTND 2.2 24.29% | SPRC 1.5001 37.62% | GPUS 0.1782 5.51% | TQQQ 69.14 4.30% | SBS 4.765 -25.55% | INTR 4.6286 -35.62% | TSLG 5.48 12.53% | RWM 14.435 -0.79% | TSLA 395.443 6.24% | SPDN 8.475 -0.76% | SQQQ 37.975 -4.30% | AAL 12.2055 0.79% | SID 0.9269 -21.45% | GGB 4.765 -6.57% | PBR-A 19.3388 -17.81% | RENT 2.9015 26.15% | LUCD 0.5155 25.43% | CIFR 8.1475 2.61% | KORU 10.9537 3.53% | WULF 12.08 6.71%
PAPhibro Animal Health Corporation logo

Phibro Animal Health Corporation (PAHC)

NASDAQ Global Market · Currency in USD
$39.30 ▲ +0.50 (+1.28%)
As of Oct 26, 12:26 PM ET. Market open.

Summary

Previous Close
$38.80
Open
$38.84
Day's Range
$38.84 – $39.41
52 Week Range
$28.25 – $60.08
Volume
19,791
Avg. Volume
243,179
Market Cap
$1.60B
Beta (5Y Monthly)
0.42
PE Ratio (TTM)
15.97
EPS (TTM)
$2.46
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
$0.48 (1.22%)
Ex-Dividend Date
Sep 2, 2026
1y Target Est
$28.00

Profile: Phibro Animal Health Corporation

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
2,605
CEO
Daniel Bendheim
Website
pahc.com

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $0.78 · Revenue est. $382.42M
DateEst.Actual
Aug 26, 2026$0.71$0.85Beat
May 6, 2026$0.72$0.76Beat
Feb 4, 2026$0.69$0.87Beat
Nov 5, 2025$0.59$0.73Beat
Aug 27, 2025$0.52$0.57Beat
May 7, 2025$0.52$0.63Beat

Analyst view

Consensus price target
$28.00 ▼ -28.7%
Range $17.00 – $49.00
Rating: Buy
Buy 43% · Hold 29% · Sell 29%

Get free alerts on PAHC and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.